Gilead Sciences (GILD) Total Debt (2009 - 2025)

Gilead Sciences (GILD) has reported Total Debt for 17 consecutive years, with $24.9 billion the latest figure, recorded in FY2025.

• Total Debt for Q1 2026 came in at $22.2 billion, down 11.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.2 billion (down 11.13% YoY), and the FY2025 annual result was $24.9 billion, down 6.65% from the prior year.
• Total Debt was $24.9 billion for FY2025 at Gilead Sciences, down from $26.7 billion in the prior year.
• Over five years, Total Debt peaked at $26.7 billion in FY2024 and troughed at $24.9 billion in FY2025.
• Average Total Debt over 5 years is $25.7 billion, with a median of $25.2 billion recorded in 2022.
• Year-over-year, Total Debt slipped 14.99% in 2021 and advanced 6.9% in 2024.
• Over 5 years, Total Debt stood at $26.7 billion in 2021, then retreated by 5.49% to $25.2 billion in 2022, then decreased by 0.96% to $25.0 billion in 2023, then rose by 6.9% to $26.7 billion in 2024, then retreated by 6.65% to $24.9 billion in 2025.
• Per Business Quant data, the three most recent Total Debt figures were $24.9 billion in FY2025, $26.7 billion in FY2024, and $25.0 billion in FY2023.